S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
OTCMKTS:PUMSY

Puma (PUMSY) Stock Price, News & Analysis

$4.45
-0.08 (-1.77%)
(As of 04/19/2024 ET)
Today's Range
$4.45
$4.51
50-Day Range
$4.20
$4.61
52-Week Range
$3.94
$7.24
Volume
47,784 shs
Average Volume
182,560 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PUMSY stock logo

About Puma Stock (OTCMKTS:PUMSY)

PUMA SE, together with its subsidiaries, engages in the development and sale of athletic footwear, apparel, and accessories in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company provides sports lifestyle products for football, handball, rugby, cricket, volleyball, track and field, motorsports, golf, and basketball. It issues licenses to independent partners to design, develop, manufacture, and sell watches, glasses, safety shoes, workwear, and gaming accessories. The company sells its products under the PUMA and Cobra Golf brands through retail stores, factory outlets, and online stores. The company was formerly known as PUMA AG and changed its name to PUMA SE in July 2011. PUMA SE was founded in 1919 and is headquartered in Herzogenaurach, Germany.

PUMSY Stock Price History

PUMSY Stock News Headlines

A Look At The Fair Value Of PUMA SE (ETR:PUM)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Puma price target lowered by EUR 8 at JPMorgan
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Puma SE ADR PUMA
The Returns At PUMA (ETR:PUM) Aren't Growing
Puma SE ADR PUMSY
Goldman Sachs Sticks to Its Buy Rating for PUMA SE NPV (PMMAF)
Puma Q2 2022 Results: Broad-Based Beats
See More Headlines
Receive PUMSY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Puma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Footwear & Accessories
Sub-Industry
N/A
Current Symbol
OTCMKTS:PUMSY
CIK
N/A
Fax
N/A
Employees
18,681
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Arne Freundt (Age 43)
    CEO & Chairman of Management Board
    Comp: $1.41M
  • Mr. Hubert Hinterseher (Age 44)
    CFO & Member of Management Board
    Comp: $1.24M
  • Ms. Anne-Laure Descours (Age 58)
    Chief Sourcing Officer & Member of the Management Board
    Comp: $1.45M
  • Ms. Maria Valdes (Age 41)
    Chief Product Officer & Member of Management Board
  • Gottfried Hoppe
    Director of Investor Relations & Finance Strategy
  • Ms. Raliza Koleva
    Chief Compliance Officer
  • Kerstin Neuber
    Senior Director Of Corporate Communications
  • Dietmar Knoess
    Vice President of People & Organization
  • Stefan Seidel
    Senior Director of Corporate Sustainability
  • Ms. Ruth How
    Head of Marketing UK

PUMSY Stock Analysis - Frequently Asked Questions

Should I buy or sell Puma stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Puma in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PUMSY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PUMSY, but not buy additional shares or sell existing shares.
View PUMSY analyst ratings
or view top-rated stocks.

How have PUMSY shares performed in 2024?

Puma's stock was trading at $5.55 at the start of the year. Since then, PUMSY stock has decreased by 18.4% and is now trading at $4.53.
View the best growth stocks for 2024 here
.

Are investors shorting Puma?

Puma saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,500 shares, an increase of 275.0% from the March 15th total of 400 shares. Based on an average daily volume of 95,600 shares, the days-to-cover ratio is currently 0.0 days.
View Puma's Short Interest
.

How do I buy shares of Puma?

Shares of PUMSY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PUMSY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners